Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Youdim

Showing results (331-340 of 349) with videos related to

Pageof 35
Sort By:
Neuropharmacology|April 1, 1987
Behavioural and biochemical evidence for the release of noradrenaline in mouse brain by TRH and some of its biologically stable analoguesD J Heal, N Stoodley, J M Elliott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Iron in the Parkinsonian substantia nigraM Gerlach, K Double, P Riederer, et al.
Advances in Neurology|January 1, 1987
Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenylP Riederer, C Konradi, V Schay, et al.
Journal of Neurochemistry|February 1, 1989
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brainsP Riederer, E Sofic, W D Rausch, et al.
Nature|March 31, 1972
Human brain monoamine oxidase: multiple forms and selective inhibitorsM B Youdim, G G Collins, M Sandler, et al.
Advances in Neurology|January 1, 1993
Iron and ferritin in substantia nigra in Parkinson's diseaseK A Jellinger, E Kienzl, G Rumpelmaier, et al.
Neuroscience|August 1, 1976
Some histological and metabolic properties of an isolated perfused rat brain preparation with special reference to monoamine metabolismH F Woods, C W Graham, A R Green, et al.
Neuropharmacology|March 1, 1980
The effects of iron deficiency on brain biogenic monoamine biochemistry and function in ratsM B Youdim, A R Green, M R Bloomfield, et al.
Journal of Neurochemistry|October 1, 1989
The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase BP Janssens de Varebeke, G Pauwels, C Buyse, et al.
Annals of the New York Academy of Sciences|May 28, 1993
The goldfish as a drug discovery vehicle for Parkinson's disease and other neurodegenerative disordersH B Pollard, M Adeyemo, K Dhariwal, et al.
Pageof 35

Showing results (331-340 of 349) with videos related to

Sort By:
Pageof 35
Neuropharmacology|April 1, 1987
Behavioural and biochemical evidence for the release of noradrenaline in mouse brain by TRH and some of its biologically stable analoguesD J Heal, N Stoodley, J M Elliott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Iron in the Parkinsonian substantia nigraM Gerlach, K Double, P Riederer, et al.
Advances in Neurology|January 1, 1987
Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenylP Riederer, C Konradi, V Schay, et al.
Journal of Neurochemistry|February 1, 1989
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brainsP Riederer, E Sofic, W D Rausch, et al.
Nature|March 31, 1972
Human brain monoamine oxidase: multiple forms and selective inhibitorsM B Youdim, G G Collins, M Sandler, et al.
Advances in Neurology|January 1, 1993
Iron and ferritin in substantia nigra in Parkinson's diseaseK A Jellinger, E Kienzl, G Rumpelmaier, et al.
Neuroscience|August 1, 1976
Some histological and metabolic properties of an isolated perfused rat brain preparation with special reference to monoamine metabolismH F Woods, C W Graham, A R Green, et al.
Neuropharmacology|March 1, 1980
The effects of iron deficiency on brain biogenic monoamine biochemistry and function in ratsM B Youdim, A R Green, M R Bloomfield, et al.
Journal of Neurochemistry|October 1, 1989
The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase BP Janssens de Varebeke, G Pauwels, C Buyse, et al.
Annals of the New York Academy of Sciences|May 28, 1993
The goldfish as a drug discovery vehicle for Parkinson's disease and other neurodegenerative disordersH B Pollard, M Adeyemo, K Dhariwal, et al.
Pageof 35